Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 163

1.

Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry.

Stangel M, Gold R, Pittrow D, Baumann U, Borte M, Fasshauer M, Hensel M, Huscher D, Reiser M, Sommer C.

Ther Adv Neurol Disord. 2016 May;9(3):165-79. doi: 10.1177/1756285616629869. Epub 2016 Feb 16.

2.

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk.

Laufs U, Karmann B, Pittrow D.

Clin Res Cardiol. 2016 Apr 27. [Epub ahead of print]

PMID:
27120330
3.

Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry.

Kistner I, Zeymer U, Dechend R, Hagedorn I, Riemer T, Bramlage P, Pittrow D, Senges J, Schmieder RE.

J Clin Hypertens (Greenwich). 2016 Apr 20. doi: 10.1111/jch.12828. [Epub ahead of print]

4.

Usefulness of Direct Oral Anticoagulants in Adult Congenital Heart Disease.

Pujol C, Niesert AC, Engelhardt A, Schoen P, Kusmenkov E, Pittrow D, Ewert P, Kaemmerer H.

Am J Cardiol. 2016 Feb 1;117(3):450-5. doi: 10.1016/j.amjcard.2015.10.062. Epub 2015 Nov 18.

PMID:
26725103
5.

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.

Hoeper MM, Behr J, Held M, Grunig E, Vizza CD, Vonk-Noordegraaf A, Lange TJ, Claussen M, Grohé C, Klose H, Olsson KM, Zelniker T, Neurohr C, Distler O, Wirtz H, Opitz C, Huscher D, Pittrow D, Gibbs JS.

PLoS One. 2015 Dec 2;10(12):e0141911. doi: 10.1371/journal.pone.0141911. eCollection 2015.

6.

Incidence and prevalence of pulmonary arterial hypertension in Germany.

Hoeper MM, Huscher D, Pittrow D.

Int J Cardiol. 2016 Jan 15;203:612-3. doi: 10.1016/j.ijcard.2015.11.001. Epub 2015 Nov 9. No abstract available.

PMID:
26580339
7.

Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany.

Gitt AK, Sonntag F, Jannowitz C, Weizel A, Karmann B, Schaefer JR, Pittrow D, Hildemann SK.

Curr Med Res Opin. 2016 Mar;32(3):417-26. doi: 10.1185/03007995.2015.1120715. Epub 2015 Dec 29.

PMID:
26568400
8.

Two-Year Outcomes of Patients Treated With Aliskiren Under Clinical Practice Conditions: Non-Interventional Prospective Study.

Zeymer U, Dechend R, Riemer T, Deeg E, Senges J, Pittrow D, Schmieder R; 3A Registry Investigators.

J Clin Hypertens (Greenwich). 2015 Nov 14. doi: 10.1111/jch.12725. [Epub ahead of print]

9.

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhäufl M, Höffken G, Held M, Koch A, Bahmer T, Pittrow D.

Eur Respir J. 2015 Jul;46(1):186-96. doi: 10.1183/09031936.00217614. Epub 2015 Apr 2.

10.

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care.

Goette A, Benninger G, Pittrow D, Paar WD, von Stritzky B, Bosch RF.

Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):148-54. doi: 10.1007/s00399-015-0360-z. Epub 2015 Mar 8.

11.

[Psychiatric and Social Aspects of Patients with Fragile X Syndrome].

Pittrow D, Gaese F, Colla M, Huss M, Kretschmar C, Brinkman M, Peters H, Elstner S, Weirich S, Häßler F.

Psychiatr Prax. 2016 Apr;43(3):160-4. doi: 10.1055/s-0034-1387517. Epub 2015 Feb 2. German.

PMID:
25643039
12.

Investigating significant health trends in idiopathic pulmonary fibrosis (INSIGHTS-IPF): rationale, aims and design of a nationwide prospective registry.

Behr J, Hoeper MM, Kreuter M, Klotsche J, Wirtz H, Pittrow D.

BMJ Open Respir Res. 2014 Jan 3;1(1):e000010. doi: 10.1136/bmjresp-2013-000010. eCollection 2014. Erratum in: BMJ Open Respir Res. 2014;1(1):e000010corr1.

13.

Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practice: Insights-Ipf Registry.

Pittrow D, Klotsche J, Kreuter M, Hoeper MM, Wirtz H, Koschel D, Claussen M, Andreas S, Grohé C, Geier S, Koppe U, Behr J.

Value Health. 2014 Nov;17(7):A600. doi: 10.1016/j.jval.2014.08.2078. Epub 2014 Oct 26. No abstract available.

14.

Current Situation of Paediatric and Adult Patients With Fragile X Syndrome: Preliminary Data From the Explain Fxs Registry.

Haessler F, Gaese F, Pittrow D, Huss M, Peters H, Kretschmar C, Brinkman M, Elstner S, Colla M.

Value Health. 2014 Nov;17(7):A505. doi: 10.1016/j.jval.2014.08.1533. Epub 2014 Oct 26. No abstract available.

15.

Discontinuation And Hospitalisation Rates In Patients With Atrial Fibrillation: Follow-Up Results Of The Prefer In Af Registry.

Brüggenjürgen B, Schliephacke T, Darius H, De Caterina R, Le Heuzey JY, Pittrow D, Reimitz PE, Schilling RJ, Zamorano JL, Kirchhof P.

Value Health. 2014 Nov;17(7):A473. doi: 10.1016/j.jval.2014.08.1346. Epub 2014 Oct 26. No abstract available.

16.

Management and outcomes of patients with reduced ejection fraction after acute myocardial infarction in cardiac rehabilitation centers.

Reibis R, Jannowitz C, Halle M, Pittrow D, Gitt A, Völler H.

Curr Med Res Opin. 2015 Feb;31(2):211-9. doi: 10.1185/03007995.2014.977854. Epub 2014 Oct 29.

PMID:
25325219
17.

1-Year outcomes of hypertension management in 13,000 outpatients under practice conditions: prospective 3A registry.

Zeymer U, Dechend R, Riemer T, Kaiser E, Senges J, Pittrow D, Schmieder RE; 3A Registry Investigators.

Int J Cardiol. 2014 Oct 20;176(3):589-94. doi: 10.1016/j.ijcard.2014.07.089. Epub 2014 Aug 1.

PMID:
25305705
18.

The impact of age on the benefits and risks of aliskiren treatment: analyses of the 3A registry.

Friedrich S, Zeymer U, Dechend R, Hagedorn I, Riemer T, Zemmrich C, Bramlage P, Pittrow D, Senges J, Schmieder RE.

J Hum Hypertens. 2015 May;29(5):316-23. doi: 10.1038/jhh.2014.86. Epub 2014 Oct 2.

PMID:
25273857
19.

Response to letters regarding article, "Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)".

Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM.

Circulation. 2014 Sep 16;130(12):e110-2. doi: 10.1161/CIRCULATIONAHA.114.010921. No abstract available.

20.

Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries.

Schweikert B, Pittrow D, Vizza CD, Pepke-Zaba J, Hoeper MM, Gabriel A, Berg J, Sikirica M.

BMC Health Serv Res. 2014 Jun 9;14:246. doi: 10.1186/1472-6963-14-246.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk